CAR T-cells are created by collecting a patient's T-cells and genetically modifying them to express CARs. Once modified, these cells are expanded in the laboratory and infused back into the patient. The engineered T-cells can then recognize and bind to specific antigens on the cancer cells, leading to their destruction. This process leverages the body's own immune system to fight cancer.
